Loading clinical trials...
Loading clinical trials...
Encorafenib/Binimetinib With or Without Nivolumab for Patients With Metastatic BRAF V600 Mutant Thyroid Cancer
Conditions
Interventions
Binimetinib
Encorafenib
+1 more
Locations
1
United States
Providence Portland Medical Center
Portland, Oregon, United States
Start Date
October 30, 2020
Primary Completion Date
December 30, 2027
Completion Date
December 30, 2028
Last Updated
April 13, 2026
NCT04693377
NCT02152995
NCT02097225
NCT02393690
Lead Sponsor
Providence Health & Services
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions